Temporary Regulatory Flexibilities
In its Inspectorate Blog the MHRA published a post on temporary changes in Good Distribution Practice (GDP) entitled “How to manage temporary GDP process changes and risks through the COVID-19 pandemic”…
China Vs Counterfeiting
With a number of reports from over the pond of Mr Trump praising China, even in areas where I think most sane people will think ‘there is room for improvement’, I am a little reluctant to join in but credit where it is due…
Buy British, will the public shun Chinese products?
As the pandemic still rages in many countries and bruised countries like the UK take their first steps to kick start the economy will we return to our normal reliance on the global supply chains?
Active Substance and Clinical Trials course
Early bird fees for our new Active Substance Course and Clinical Trials course being run next Tuesday- 23rd June, 20th of July and 11th of August will be applied to bookings made within a week of the course.
API and Clinical Trails Training
Shankar Seetharaman is a Qualified Person with many years of experience in API auditing and clinical trials supply. He currently is the Managing Director of Pharmanswers Ltd which is a consultancy with a proven track record of providing quality and regulatory support for the pharmaceutical industry…
UK trade agreement
More trade is essential if the UK is to overcome the unprecedented economic challenge posed by the Coronavirus. The UK’s priority is to launch negotiations with the EU, the US, Australia, New Zealand and Japan…